Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Federal Trade Commission
Baxter
Daiichi Sankyo
Covington

Generated: June 26, 2019

DrugPatentWatch Database Preview

Litigation Details for In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)

Try a free trialSee Plans and Pricing

« Back to Dashboard

In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)

Docket ➤ Try a Free Trial Date Filed 2014-12-12
Court District Court, N.D. Illinois Date Terminated
Cause 28:1331 Federal Question Assigned To Harry Daniel Leinenweber
Jury Demand Defendant Referred To
Parties (DIRECT PURCHASER AND END-PAYOR); ALBERTSONS LLC; ALL PLAINTIFFS AND DEFENDANTS; CVS PHARMACY, INC.; DIRECT PURCHASER PLAINTIFFS; END-PAYOR PLAINTIFFS; ENDO HEALTH SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; FRATERNAL ORDER OF POLICE, MIAMI LODGE 20 INSURANCE TRUST FUND; HEB GROCERY COMPANY L.P.; IMPAX LABORATORIES, INC.; INTERNATIONAL UNION OF OPERATING ENGINEERS, LOCAL 138 WELFARE FUND; KIM MAHAFFAY; LOUISIANA HEALTH SERVICE AND INDEMNITY COMPANY; MARY DAVENPORT; MASSACHUSETTS BRICKLAYERS & MASONS HEALTH AND WELFARE FUND; MEIJER DISTRIBUTION, INC.; MEIJER, INC.; OPANA ER ANTITRUST LITIGATION; PENNSYLVANIA EMPLOYEES BENEFIT TRUST FUND; PENWEST PHARMACEUTICALS CO.; PLUMBERS & PIPEFITTERS LOCAL 178 HEALTH & WELFARE TRUST FUND; RETAILER PLAINTIFFS; RITE AID CORPORATION; RITE AID HDQTRS. CORP.; ROCHESTER DRUG CO-OPERATIVE, INC.; SAFEWAY INC.; SERVICE LIST; THE KROGER CO.; VALUE DRUG COMPANY; WALGREEN CO; WISCONSIN MASONS' HEALTH CARE FUND
Patents 5,128,143; 5,662,933; 5,958,456; 7,276,250
Attorneys (Direct Purchaser and End-Payor); Aaron Schwartz; All Plaintiffs and Defendants; Andrew C. Curley; Andrew M. Purdy; Andrew W Kelly; Angela M. Liu; Anna Maria Fabish; Anna T Neill; Anne M. Schmidt; Archana Tamoshunas; Barry L Refsin; Benedict Yung Hur; Benjamin M Greenblum; Brian M. Hogan; Brian Savage; Bruce E. Gerstein; Carol V Gilden; Caroline Petro Gately; Carolyn M. Hazard; Chad Joseph Primeaux; Charles A. O'Brien , III; Chris Letter; Christine C Levin; Christopher Alden Yeager; Christopher Taylor Stow-Serge; Craig G. Falls; Daniel E Gustafson; Danielle R Foley; David Baylis Franco; David C. Raphael; David F. Sorensen; David Lesht; David P Germaine; David S. Scalia; David W. Rizk; Direct Purchaser Plaintiffs; Donald Lewis Sawyer; Douglas J. Moore; Douglas Richards; Douglas Robert Plymale; Eric L. Bloom; Erin R Leger; Frank R. Schirripa; Gary L. Specks; George Gabriel Gordon; Gregory Asciolla; Hiba Hafiz; James Boone Baxter; James Douglas Baldridge; James Gerard Beebe Dallal; James Patrick Schaefer; James R. Dugan, ii; Jason S. Kilene; Jay L Himes; Jayne Goldstein; Jeffrey L. Kodroff; Jennings F. Durand; Joanna Rubin Travalini; John Angelo Macoretta; John G. Harkins , Jr.; John McClam; John Paul Bjork; Jonathan M Gerstein; Jordan M. Cramer; Joseph Michael Vanek; Joseph Opper; Joseph R. Saveri; Joseph T. Lukens; Joshua David Hess; Joshua P. Davis; Justin Nicholas Boley; Karin E. Garvey; Kenneth A. Wexler; Kenneth R. O'Rourke; Kevin Fitzgerald Wolff; Kristin M. Koger; Lauren C Ravkind; Lawrence R. Desideri; Lewis Scott Joanen; Lisa Jose Fales; Lynne Marie Brennan; Matthew J Perez; Matthew P. Mccahill; Matthew S. Weiler; Maureen L Rurka; Maureen Smith Lawrence; Meera Unnithan Sossamon; Meijer, Inc.; Michael Jerry Freed; Michael K Klinger; Miranda Y Jones; Monica L. Kiley; Morgan J. Feder; Natalie Finkelman Bennett; Nathan E Hoffman; Neill C. Kling; Paul Costa; Paul Ethan Slater; Peter R. Kohn; Quentin F Urquhart , Jr; Quinn Colleen Shean; Ralph B. Kalfayan; Rebuck L. Monica; Retailer Plaintiffs; Richard Daniel Schwartz; Richard J. Kilsheimer; Robert J. Wozniak; Robert N. Kaplan; Robert Samuel Kitchenoff; Roberta D. Liebenberg; Russell A. Chorush; Ryan J. Mcewan; Scott E Perwin; Sharon K Robertson; Stephen McIntyre; Steven A Kanner; Susan C Segura; Susan Harriman; Thomas Arthur Doyle; Thomas Jon Maas; Thomas Miller; Todd Clark Jacobs; Zachary David Caplan
Firms Berger & Montague, P.C.; Berger Montague PC; BR>Trial Bar Status: Active; BR>Trial Bar Status: Not a Member; BR>Trial Bar Status: Pro Hac Vice; Bradley Riley Jacobs PC; Chad Joseph Primeaux; Charles A. O'Brien , III; Cohen Milstein Sellers & Toll PLLC; Cohen Milstein Sellers & Toll, PLLC; Cohen Milstein Sellers Toll PLLC; Dechert LLP; Dechert LLP (Philadelphia); Dechert, LLP; Faruqi and Faruqi LLP; Fine, Kaplan and Black; FrancoLaw, PLLC; Freed Kanner London and Millen LLC; Freed Kanner London Millen LLC; Garwin Gerstein & Fisher; Garwin Gerstein & Fisher LLP; Garwin, Bronzaft, Gerstein & Fisher; George Gabriel Gordon; Hach Rose Schirripa & Cheverie, LLP; Hangley Aronchick Segal Pudlin & Schiller; Hangley Aronchick Segal Pudlin and Schiller; Hangley Aronchick Segal Pudlin Schiller; Heim, Payne & Chorush LLP; Irwin Fritchie Et Al; Irwin Fritchie Urquhart & Moore LLC; John G. Harkins , Jr.; John McClam; Joseph Saveri Law Firm; Joseph Saveri Law Firm, Inc.; Kaplan Fox & Kilsheimer LLP; Kaplan, Kilsheimer & Fox LLP; Keker & Van Nest LLP; Keker, Van Nest & Peters LLP; Kenny Nachwalter P.A.; Keogh Law Ltd; Krause Kalfayan Benink and Slavens LLP; Labaton Sucharow LLP; Labaton Sucharow LLP-NY; Law Offices of Eugene M. Cummings, P.C.; Law Offices of Jordan M. Cramer, PC; Neill C. Kling; O'Melveny & Myers LLP; Odom & Des Roches; Odom & Des Roches, LLC; Scott E Perwin; Shepherd Finkelman Miller & Shah; Shepherd Finkelman Miller & Shah LLC; Shook, Hardy & Bacon LLP; Skadden Arps Slate Meagher and Flom LLP; Smith Segura & Raphael, LLP; Spector Roseman & Kodroff, P.C.; Spector, Roseman & Kodroff, P.C.; Spector, Roseman Kodroff & Willis, P.C.; Sperling & Slater; Sperling & Slater, P.C.; The Dugan Law Firm; The Dugan Law Firm, APLC; The Law Office of Thomas J. Maas, LLC; Thomas Miller; Vanek Vickers & Masini; Vanek, Vickers & Masini, P.C.; Venable LLP; Weinstein Kitchenoff and Asher LLC; Wexler Wallace; Wexler Wallace LLP; Williams & Connolly LLP; Winston & Strawn; Winston & Strawn LLP; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in In Re: Opana ER Antitrust Litigation
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)

Date Filed Document No. Description Snippet Link To Document
2015-05-04 102 Co.) obtained patents related to time release formulations: U.S. Patent No. 5,128,143 entitled “Sustained…the Orange Book patents because: (1) no patents exist on the brand drug; (2) the patents have expired;…artificial act” of patent infringement, permitting the patent owner to file a patent infringement suit…ER. This patent is expected to provide patent protection until November 2023. The new patent will be listed…limitations on the types of patents that can be listed. Only drug substance patents (active ingredient), drug External link to document
2016-02-10 151 purchased the rights to four patents — U.S. Patent No. 5,128,143 (the “143 patent”), No. 5,958,456 (the …of any unexpired patents listed in the Orange Book; or (IV) that any unexpired patents listed in the Orange…artificial act” of patent infringement, permitting the brand company to file a patent infringement suit… “‘456 patent”), No. 5,662,933 (the “‘933 patent”), and No. 7,276,250… ‘143 patent in the Orange Book as covering Opana ER, and later added the ‘456 and ‘933 patents. External link to document
2016-02-25 162 rights to four patents — U.S. Patent No. 5,128,143 (the “‘143 patent”), No. … “‘456 patent”), No. 5,662,933 (the “‘933 patent”), and No. 7,276,250 (the “‘250 patent”) (collectively…expiration of the Penwest Patents, and Endo sued each for patent infringement. RAC ¶¶ 84-109…enforceability of the ‘933 and ‘456 patents, as well as the ‘250 patent, which Endo had not even accused…agreement to settle ongoing patent infringement Case: 1:14-cv-10150 Document External link to document
2016-03-02 164 Co.) obtained patents related to time release formulations: U.S. Patent No. 5,128,143 entitled “Sustained…the Orange Book patents because: (1) no patents exist on the brand drug; (2) the patents have expired;…artificial act” of patent infringement, permitting the patent owner to file a patent infringement suit…ER. This patent is expected to provide patent protection until November 2023. The new patent will be listed…limitations on the types of patents that can be listed. Only drug substance patents (active ingredient), drug External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Federal Trade Commission
Johnson and Johnson
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.